| Literature DB >> 31877995 |
Hongjie Yuan1, Ping Lan2, Yan He1, Chengliang Li3, Xia Ma1.
Abstract
β-Glucan exhibits many biological activities and functions such as stimulation of the immune system and anti-inflammatory, anti-microbial, anti-infective, anti-viral, anti-tumor, anti-oxidant, anti-coagulant, cholesterol-lowering, radio protective, and wound healing effects. It has a wide variety of uses in pharmaceutical, cosmetic, and chemical industries as well as in food processing units. However, due to its dense triple helix structure, formed by the interaction of polyhydroxy groups in the β-d-glucan molecule, it features poor solubility, which not only constrains its applications, but also inhibits its physiological function in vivo. One aim is to expand the applications for modified β-glucan with potential to prevent disease, various therapeutic purposes and as health-improving ingredients in functional foods and cosmetics. This review introduces the major modification methods required to understand the bioactivity of β-glucan and critically provides a literature survey on the structural features of this molecule and reported biological activity. We also discuss a new method to create novel opportunities to exploit maximally various properties of β-glucan, namely ultrasound-assisted enzymatic modification.Entities:
Keywords: anti-oxidation; biological activity; functions; modification; polysaccharides; soluble; β-glucan
Mesh:
Substances:
Year: 2019 PMID: 31877995 PMCID: PMC6983044 DOI: 10.3390/molecules25010057
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Composition of the yeast cell wall.
Figure 2The structure of yeast β-glucan (a) One-dimensional structures of yeast β-glucan; (b) Three-dimensional structure of yeast β-glucan.
Figure 3Possible conformations of polysaccharides in aqueous solution.
Figure 4Major methods of molecular modification of β-glucan.
Isolation and purification, water-soluble β-glucan yield and MWs produced by different modification methods.
| Water Soluble β-Glucan | Modification Methods | Isolation and Purification | Yield | MW | Ref. |
|---|---|---|---|---|---|
| 1,3-/1,6-glucan | Heat degradation | Centrifuged at 3,000 rpm for 20 min; filtered through a 0.45 µm disposable syringe filter | 89.8% | 70.8 × 104 | [ |
| Black yeast β-Glucan | Irradiation 10, 30 and 50 kGy | _ | 55.76%, 75.81%, 81.72% | 6.2 × 104, 3.2 × 104, 2.5 × 104 | [ |
| Ultrasonic treatment | Ultrafiltration using a membrane with a MW cut-off of 10 kDa | PCS90 6.30 mg/mL (Solubility) | 4.3 × 104 | [ | |
| Yeast β-glucan | High pressure micro-jet | Ethanol precipitationcentrifugation | 79.3% | [ | |
| Sulfation | Ultrafiltration system (Sartorius. Co. SM 17521), using a 10,000 MW cut-off filter | 85% | 9.3 × 103 | [ | |
| Phosphorylation | 1 µm pre-filter Pellicon tangential flow dialyzer (Millipore, Bedford, MA) | 70% | 1.28 × 106 −0.25 × 105, 3.57 × 106 −1.10 × 105, 12.23 × 106 −3.04 × 105 | [ | |
| Yeast β-1,3-glucan | Enzymic | Sephadex G-100 | 52% | 6.380 × 108, 4.785 × 107, 1.206 × 106 | [ |
Figure 5Possible immune mechanism of the β-d-glucans biological response modifier.